Intel Stock Stabilizes Near $87 After Sharp Selloff as Investors Debate Quality of AI Revenue Growth

Intel shares steadied Wednesday morning, trading at $86.72, up 49 cents or 0.49%, following a sharp two-day decline that has left the chipmaker's stock down roughly 15% from levels seen just last week despite the company posting quarterly results that beat Wall Street's forecasts.

The modest rebound comes after Intel shares fell 5.9% on Tuesday to close at $86.30, extending losses from earlier in the week even though the company's second-quarter earnings, released last week, had exceeded analyst expectations on multiple key metrics. The stock's recent volatility has left investors debating whether Intel's underlying growth is as strong as the headline numbers suggest, or whether deeper questions about the composition of that growth justify the market's more cautious reaction.

Intel reported second-quarter revenue of $16.1 billion, up 25% year over year and ahead of the high end of the company's own guidance, which had called for revenue of up to $14.8 billion. The company also issued third-quarter revenue guidance of $16.3 billion at the midpoint, which would represent 19% year-over-year growth and would exceed the consensus analyst estimate of $15.1 billion compiled by FactSet. Data Center and AI revenue climbed 59% year over year to $6.3 billion, while the company's Client Computing Group division saw revenue rise 15% sequentially to $8.9 billion, even as the broader personal computer market has continued to face a gradual decline in unit demand.

Despite those figures, Intel shares initially rose only modestly after the earnings release before reversing sharply in the days that followed. Shares had briefly climbed 3.44% in after-hours trading immediately following the results, reaching $103.68, before giving back those gains and more over the subsequent trading sessions. Management, discussing the results with analysts, pointed to supply constraints and intensifying competition as key risks facing the company going forward, even as they highlighted strong customer demand as justification for raising the company's 2026 capital expenditure forecast to more than $20 billion, with plans for a further increase in 2027.

Analysts have offered a range of explanations for the disconnect between Intel's better-than-expected results and its subsequent stock decline. Much of the debate has centered on the composition and sustainability of Intel's growth rather than the headline figures themselves, with some market participants raising questions about how much of the company's recent momentum is tied to durable demand trends versus shorter-term factors that may not persist into future quarters.

Intel's balance sheet has drawn particular scrutiny amid the stock's decline, given the scale of capital spending the company has committed to as part of its push to expand advanced chip manufacturing capacity. At the end of June, Intel reported $29.73 billion in cash and short-term investments, while total debt stood at $50.54 billion, up from $46.59 billion at the end of December. Operating cash flow for the first half of the year totaled $8.10 billion, a significant improvement from $2.86 billion during the same period a year earlier. The company also maintains access to a $10 billion credit facility, and while no new equity offering is currently authorized, company management has not ruled out the possibility of issuing additional stock to help fund its expanding capital expenditure commitments.

Even after the recent pullback, Intel's valuation remains a point of contention among analysts. The company ended Tuesday's session with a market capitalization near $435 billion. Because Intel has posted negative trailing earnings on a GAAP basis, traditional price-to-earnings comparisons are not meaningful for the stock, though using the midpoint of the company's third-quarter revenue guidance on an annualized basis puts Intel's valuation at roughly 6.7 times sales. Based on forward earnings estimates, the stock's current price of around $85 implies a valuation of nearly 42 times projected 2027 earnings, a multiple that has come down somewhat from earlier in the month as the share price has declined, though analysts note significant execution risk remains embedded in that figure.

Consensus earnings estimates for Intel have moved sharply higher over the past month even as the stock has fallen. FactSet data shows that consensus earnings-per-share projections for 2026 rose 37% over the past month, while 2027 estimates climbed 28% over the same period, reflecting analysts' improving confidence in the company's near-term profitability even as the market's valuation of the stock has moved in the opposite direction.

Intel's stock has traded within an unusually wide 52-week range, spanning a low of $18.97 to a high of $142.35, reflecting the volatility that has characterized the company's turnaround effort under its current leadership as it works to regain competitiveness against rivals in both the personal computer and data center chip markets. The average 12-month analyst price target for the stock currently sits at $115.27, with estimates ranging from a low of $74 to a high of $200, and 14 of the 17 analysts covering the stock currently rating it a buy, according to compiled analyst data, suggesting many Wall Street observers view the recent pullback as a potential buying opportunity rather than a signal of deteriorating fundamentals.

Intel's next quarterly earnings report is scheduled for October 22, giving investors roughly three months to assess whether the company's third-quarter results can help resolve the current debate over the durability of its recent revenue growth, particularly within its fast-expanding data center and artificial intelligence product lines.